Hyperkalemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-12-23
Clinical Trial Update: IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
The clinical trial evaluating the impact of hyperkalemia on therapy with renin-angiotensin-aldosterone system inhibitors has been withdrawn.